News - Medical and health professional investment - VC and PE investment business - Shenzhen Efung Investment Management Co. Ltd.

发布时间: 2026 - 09 - 01

Efung Honor | Efung Capital Wins Dual Awards! Named to [Investors China] 2025-2026 Fund Partners Ran

Recently, Investors China released its prestigious 2025-2026 Fund Partners Ranking. Efung Capital has been honored as one of the Top 50 Best Venture Capital Institutions of 2025-2026, and our CEO, Mr. Zhu Pai, has been recognized among the Top 30 Best Venture Capital Investors of 2025-2026.Over the past year, China's equity investment industry has undergone a profound restructuring and value redefinition. The speculative logic that once profited from hot trends and quick flips is gradually losing its effectiveness. In its place emerges a new competitive landscape rooted in indust...

浏览次数：7

查看详情>>

发布时间: 2026 - 08 - 31

Monthly Health Read | August 2026

In August 2026, competition intensified around the evolution of AI large models toward Agents, the commercialization of embodied intelligence, and breakthroughs in frontier medical technologies such as brain-computer interfaces. The venture capital market exhibited notable characteristics including sustained strong interest in the AI sector, active financing activities in hard tech and healthcare, and robust global VC performance.Against this backdrop, multiple portfolio companies of Efung Capital achieved consecutive breakthroughs in financing rounds and core business expansion.Portfolio...

浏览次数：2

查看详情>>

发布时间: 2026 - 08 - 28

Efung Knowledge Planet | China's Youngest Generation of Innovative Drug Leaders Is Rewriting the Ind

Editor's Note: In recent years, China's innovative drug industry has been undergoing a profound generational transition. The previous generation of entrepreneurs, leveraging hands-on experience accumulated at multinational pharmaceutical companies, completed the path from 0 to 1. Meanwhile, a cohort of post-80s and post-90s scientists are now exploring entirely new drug R&D paradigms atop the existing industrial foundation, using cutting-edge tools such as AI-driven drug discovery, organ-on-a-chip technology, and small nucleic acid delivery systems. This article is approximate...

浏览次数：3

查看详情>>

发布时间: 2026 - 08 - 26

Efung Honor | Efung Capital Secures Three Awards on Qimingpian's 2026 Mid-Year Equity Investment Ser

Recently, Qimingpian officially released its 2026 Mid-Year Equity Investment Series Institution Rankings. Efung Capital was honored on three prestigious lists:Top 50 Most Active Venture Capital Institutions in ChinaTop 50 Comprehensive Venture Capital Institutions in ChinaTop 20 Investment Institutions in the Healthcare SectorIn the first half of 2026, China's equity investment market demonstrated a pattern of structural recovery alongside ongoing adjustments, with overall vitality continuing to release. Fundraising showed notable improvement, with both the number and scale of newly raised...

浏览次数：6

查看详情>>